Embodiments of the present invention are directed to methods for treatment of melanoma using an inhibitor of dihydroorotate dehydrogenase (DHODH) and to combination therapies that involve administering to a subject an inhibitor of oncogenic BRAF (e.g. BRAF(V600E)), as well as an inhibitor of dihydroorotate dehydrogenase (DHODH). Assays for identifying compounds useful for the treatment of melanoma are also provided. The methods comprise screening for compounds or agents that inhibit neural crest progenitor formation in a zebra fish model of melanoma.
本发明的实施方案涉及使用二氢
烟酸脱氢酶(DHODH)
抑制剂治疗
黑色素瘤的方法,以及涉及向受试者施用致癌BRAF(例如BRAF(V600E))
抑制剂以及二氢
烟酸脱氢酶(DHODH)
抑制剂的联合疗法。还提供了用于鉴定治疗
黑色素瘤的化合物的检测方法。这些方法包括在
黑色素瘤斑马鱼模型中筛选抑制神经嵴祖细胞形成的化合物或制剂。